Latest news with #Maven
Axios
2 days ago
- Business
- Axios
Exclusive: Maven AGI raises $50M Series B
Maven AGI, which builds enterprise AI agents for customer support, raised a $50 million Series B led by Dell Technologies Capital, co-founder and CEO Jonathan Corbin tells Axios Pro. Why it matters: AI agents are all the rage right now, especially in areas stretched thin, like customer service. State of play: Several startups have raised money for AI customer service agents, including Parloa's massive $120 million Series C last month. How it works: Maven's agents are designed specifically for large enterprises, integrating with the myriad systems used by big companies and cleaning up old data sets. Maven's autonomous agents resolve up to 93% of customer questions, Corbin said. The company's AI agents can also be used internally by companies to support workflows. Zoom in: The round also included participation from Cisco Investments, SE Ventures, Pathlight Ventures, Lux Capital, M13 and E14. Founded in 2023, the Boston-based company has now raised a total of $78 million. By the numbers: In less than 12 months, Maven has scaled from zero to $7 million in annual recurring revenue, per the company. It has signed up 30 enterprise customers in its first year, including Tripadvisor, Clio and Paris Hilton's Parivie beauty line. What they're saying:"Maven just stands out in this very crowded landscape," Elana Lian, partner at Dell, says about investing in the very competitive agentic AI customer service sector.
CNBC
2 days ago
- Business
- CNBC
Oura, Maven Clinic team up to bring biometric data into clinical care
Women's and family health platform Maven Clinic is partnering with smart ring maker Oura, a step forward in the integration of the increasing amount of data being collected by wearable devices and clinical care. As part of the partnership, eligible Maven members will be able to sync the data that their Oura Ring collects with the Maven platform, allowing members of the Maven care team to comb over the Oura-collected data like sleep, stress and activity to provide enhanced health guidance. Maven Clinic, a three-time CNBC Disruptor 50 company, is the largest virtual clinic for women's and family health with more than 2,000 employers and health plans using its platform. The company, which raised a $125 million funding round valuing it at $1.7 billion in October 2024, offers programs that range from fertility and family building to maternity and newborn care to menopause and midlife health. Kate Ryder, CEO and founder of Maven Clinic, said that we're in a "reinvigorated era of consumer health," a period that is being defined by the amount of data being collected via wearables and the desire of people to use those diagnostics to seek treatment and advice. Ryder said that a recent survey of Maven Clinic members found that nearly three out of four members are tracking their health regularly with some sort of device, and consumers are asking, "How do I take my health into my own hands with all these tools and areas of wellness at my fingertips to try to live a healthier life?" That shift prompted Maven's new partnership with Oura, also a three-time Disruptor 50 company, which was ranked No. 23 on the 2025 CNBC Disruptor 50 list and has been on its own path of wellness and preventive health via its eponymous Ring in recent years. While Oura's initial focus centered on tracking sleep and recovery metrics, its scope has widened significantly in recent years to broader healthcare and personal health issues. As Oura CEO Tom Hale said in a recent CNBC interview, "the vision for the future of Oura has to do with the doctor in your pocket." That includes a wide variety of metrics, features and health indicators tracked by the Oura Ring and parsed by the company's AI and analytics to offer wearers' health insights, including a variety of female-focused features around menstrual, period and pregnancy cycles. "One of our key theses is that women have been overlooked in science, and in health understudied and overlooked, but we believe that they expect the same level of personalization, transparency and immediacy from their healthcare," said Oura chief commercial officer Dorothy Kilroy. "This is what they want, and traditional healthcare hasn't really kept up with that for women and their families." Kilroy said that the partnership between the two companies aims to deliver that, offering "smart, connected personalized care that'll fit into their lives and not the other way around, which is kind of what the old healthcare systems have provided." The ultimate goal is to improve health outcomes through the utilization of the data collected by the Oura Ring, allowing for more personalized recommendations, the ability to catch issues sooner and be more proactive, and layering in expert medical care at critical points. "Tracking is the first step, but really it's not just about surfacing health data," Ryder said, noting that Maven Clinic is the first virtual care platform to turn Oura's health signals into expert care. "We really want to act on it to actually drive better outcomes." One example of how the data could be utilized would be in the case of a pregnant Maven member diagnosed with gestational diabetes. That person could work with a Maven nutritionist or support coach to help regulate their glucose levels, while using Oura's physical activity tracking and meals and glucose features to monitor their progress. Oura is increasingly working with a variety of partners in the healthcare sector to use the biometric data collected by its Rings, Kilroy said, allowing it to be "paired with clinical care and creating that kind of seamless experience where the members can both understand what's going on in their body but they can actually use that to get expert care all in one place." Ryder said that she sees the convergence of this sort of biometric tracking and the clinical side as leading towards much more effective preventative care, leading to "much better outcomes," especially among high-risk patients where this sort of reporting and engagement can result in significant improvements in health. Maven Clinic will start to integrate the Oura data into its platform starting later this summer, with a goal of having it reach all members who want to opt in by the winter. Maven members will also receive exclusive pricing on the purchase of an Oura Ring. "We have to shift our healthcare system into prevention and invest more in wellness and wellbeing," Ryder said. "There's a lot of exciting stuff that this partnership can do to take the step forward, be innovative and show the outcomes on the back end."
Yahoo
2 days ago
- Business
- Yahoo
Is Palantir Stock Poised to Surge Amidst the Israel-Iran Conflict?
Tensions flared across the Middle East in June 2025 as Israel launched a series of strikes on Iranian nuclear and military sites, igniting fears of a broader regional war. Oil (CLN25) prices spiked, global markets quivered, and defense stocks roared to life as uncertainty rippled through investor sentiment. The specter of all-out conflict looms, with geopolitical fault lines growing sharper by the day. Amid this chaos, Palantir Technologies (PLTR) has emerged as a unique investment opportunity. Known for advanced data analytics, it's been quietly powering intelligence and battlefield logistics. Since October, it has supplied battlefield-grade AI tools through a strategic partnership with Israel's Ministry of Defense - technology that's now center stage amid escalating conflict. Palantir's data fusion platforms help governments act on chaos, making it a critical asset in physical warfare and digital disruption. Trump Is Giving Tesla's Robotaxis a Leg Up Ahead of June 22. Should You Buy TSLA Stock Now? Dear Nvidia Stock Fans, Mark Your Calendars for July 16 The Trump Family Is Betting Big on Mobile Phones. Should Apple Stock Investors Be Worried? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Back in the U.S., Palantir hit a defense jackpot, with the Department of Defense expanding its Maven Smart System contract ceiling from $480 million to $1.275 billion, while NATO's adoption of Maven gave the stock another jolt. As defense spending climbs amid escalating conflicts and AI tools gain traction, PLTR surged to earn the top S&P 500 Index ($SPX) slot. But can this high-flying rocket keep soaring, or is turbulence waiting just ahead? Founded in 2003, Palantir Technologies (PLTR) has evolved into a commanding presence in the AI and data integration domain. What began as a mission to aid counterterrorism now spans cutting-edge platforms - Gotham for governments, Foundry for enterprises, and the rapidly ascending Artificial Intelligence Platform (AIP), launched in 2023. These tools empower institutions to harness vast data troves with surgical precision. Operating across four continents, Palantir does not just process information; it weaponizes it for clarity, compliance, and strategic dominance in an increasingly complex world. Valued at a market cap of $333.7 billion, PLTR stock is a software titan in the large-cap arena. The stock has been tearing through resistance, skyrocketing nearly 83% on a YTD basis. The stock first touched the $140 mark on June 11 and has since surged to new highs above $144. But zoom out, and the story gets even more interesting. Over the past 52 weeks, the stock surged 452%, and after stretching that lens, PLTR climbed a stunning 747% across two years, and an exceptional 1,567.5% surge over the past three years. Even with PLTR stock tearing through new highs, its valuation is hitting nosebleed territory. A forward adjusted price-earnings ratio of 243x and a price-sales ratio of 85.9x are exorbitant, even for a hypergrowth software company. Palantir reported impressive first-quarter 2025 earnings on May 5. The company's revenue surged 39% year over year to $884 million, edging past Wall Street's estimates, and momentum showed no signs of slowing. Meanwhile, adjusted EPS climbed by 62.5% annually to $0.13. Palantir's AIP is what is fueling this rocket, catching fire across both government and commercial sectors. The government segment generated $487 million in revenue, up 45% annually, with U.S. government revenue accounting for $373 million, also growing 45%. At the heart of this surge was deepening ties with the Department of Defense. In the U.S., total revenue spiked 55% year over year to $628 million. But the real head-turner was U.S. commercial revenue, which pulled $255 million, up a staggering 71% annually. Bookings surged 183%, hitting $810 million - the strongest total contract value (TCV) Palantir has ever recorded in its commercial U.S. operations. Customer growth has followed suit, now at 769 total customers, up 39% year over year. And these are not casual contracts. Average revenue from its top 20 clients rose 26% to $70 million. On the government side, Palantir secured $1.5 billion in TCV, including a new NATO partnership and deeper inroads in the U.K.'s healthcare and defense sectors. Plus, the company wrapped the quarter with $5.4 billion in cash and zero debt. And with a quarter that strong, of course, guidance had to rise. Palantir now expects full-year revenue between $3.89 billion and $3.902 billion, marking nearly 36% annual growth. U.S. commercial alone is anticipated to top $1.178 billion, up at least 68%. With 2025 free cash flow projected between $1.6 billion and $1.8 billion, and Q2 revenue poised to be between $934 million and $938 million, Palantir might just be getting started. Analysts tracking Palantir expect 2025 profit to reach $0.37 per share, up 362.5% year-over-year, and rise another 18.9% to $0.44 per share in fiscal 2026. Last week, Loop Capital turned up the volume on PLTR stock, hiking its price target to $155 from $130 and doubling down on its 'Buy' rating. Loop called Palantir an 'early software leader' in enterprise AI. The analyst was impressed with AIP, booming AI trends, and the company's edge in a rapidly scaling market. Wall Street's sentiment on PLTR stock is clearly split - bulls see promise, skeptics preach caution. The stock has a consensus 'Hold' overall. Of the 20 analysts offering recommendations, three advise a 'Strong Buy,' 12 analysts play it safe with a 'Hold,' one suggests a 'Moderate Sell,' and the remaining four maintain a 'Strong Sell.' Although the stock is trading at a premium to its average analyst price target of $104.94, the Street-high target of $155 signals that PLTR can still climb as much as 12% from current levels. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Time of India
4 days ago
- Entertainment
- Time of India
Vince McMahon's short but powerful words after Maven Huffman's injury
is a man who lives and breathes wrestling, and for many WWE Superstars, he's a tough boss, a strong leader, and someone whose opinion can make or break a career. Maven Huffman, a former superstar, has shared about his struggles under Mr. Tired of too many ads? go ad free now McMahon's watch, sharing a dramatic moment when he kept wrestling even with a serious injury just to keep going for the fans. This is a story that shows just how much pressure is placed on a superstar. Maven's match against Christian back in 2002 was a big moment in his career, a moment that proved his toughness, loyalty, and ability to keep going, even when things get difficult. What was Vince McMahon's reaction to Maven Huffman's injury? Back in 2002, was still a newcomer in WWE. He had won Tough Enough and was making a name for himself. But during a match with Christian on SmackDown, something went wrong, Maven broke his leg. The moment was painful, but instead of stopping, Maven kept wrestling, much to Mr. McMahon's happiness. Speaking to his Youtube channel Maven shared: 'The thought of not continuing never entered my mind. I knew we were in front of an audience, and more importantly, I knew Vince McMahon was right back there. He didn't even know my leg was broken until later on that night. When someone told him, he said, 'Finish the match,' and he was happy. That's just a big wrestler thing: if you get injured, you continue, you finish.' My Wife Reacts to My Spiciest WWE Moments While Maven recovered from his injured leg, he had to take a break from wrestling for six months, a dramatic pause in a career that was just starting to grow. The moment Maven Huffman and Vince McMahon Connected Maven's choice to keep going showed more than just toughness. It proved he and Vince shared a bond built on trust and respect. Tired of too many ads? go ad free now Vince trusted Maven to do what was right for the show, and Maven trusted Vince's words to guide him. The Worst Injury of My WWE Career! s simple order, 'Finish the match', became a lesson for wrestlers everywhere. It reminded everyone that even when you feel you can't go on, you dig deep and push through. For Maven, it was a test of will. For Vince, it was proof that his words could inspire real bravery. Vince McMahon is a man whose decisions can make or break a superstar's future. Maven's experience shows that Mr. McMahon's tough discipline pushes you forward. That moment made Maven's name stand out in WWE history. It showed every wrestler that sometimes the hardest thing you do is keep going. Also Read:
Belfast Telegraph
6 days ago
- Business
- Belfast Telegraph
Sisters behind Belfast boutique inspired by dad's entrepreneurial spirit: ‘We always talked business at the dinner table'
Founders of Maven high-end furniture store on Lisburn Road say parents a big influence on their decision to take plunge For sisters Patricia and Catherine McGinnis, Father's Day is a chance to thank their dad for passing on his entrepreneurial genes. Owners of Maven, a high-end furniture store on Belfast's Lisburn Road, the sisters — two of five siblings — have learned plenty of business lessons from dad John, owner of The McGinnis Group.
